OneMedNet Announces Additional $3.7 Million of Funding in Private Placement Transactions and Approximately $11 Million in Reductions in Liabilities
OneMedNet (Nasdaq: ONMD), a provider of regulatory-grade imaging Real-World Data, has secured $3.7 million in funding through private placement transactions at $0.42 per share. The company has also significantly improved its financial position by reducing liabilities by approximately $11 million, representing a 60% reduction in total liabilities as of March 31, 2025.
The liability reduction includes settling $3.26 million in deferred underwriter fees, $1.08 million in trade payables, converting $6.56 million of principal and interest into common stock, and redeeming $250,000 in convertible notes. The company plans to use the new funding for working capital and general corporate purposes, while continuing its strategy of adding Bitcoin to its balance sheet.
OneMedNet (Nasdaq: ONMD), fornitore di dati di imaging Real-World di qualità regolatoria, ha ottenuto un finanziamento di 3,7 milioni di dollari tramite collocamenti privati a 0,42 dollari per azione. L'azienda ha inoltre migliorato significativamente la propria posizione finanziaria riducendo le passività di circa 11 milioni di dollari, pari a una riduzione del 60% delle passività totali al 31 marzo 2025.
La riduzione delle passività comprende il pagamento di 3,26 milioni di dollari di commissioni differite agli underwriter, 1,08 milioni di dollari di debiti commerciali, la conversione di 6,56 milioni di dollari di capitale e interessi in azioni ordinarie e il riscatto di 250.000 dollari in obbligazioni convertibili. La società intende utilizzare i nuovi fondi per il capitale circolante e scopi aziendali generali, continuando al contempo la strategia di aggiungere Bitcoin al proprio bilancio.
OneMedNet (Nasdaq: ONMD), proveedor de datos de imágenes Real-World con calidad regulatoria, ha asegurado un financiamiento de 3,7 millones de dólares mediante colocaciones privadas a 0,42 dólares por acción. La compañía también ha mejorado significativamente su posición financiera al reducir sus pasivos en aproximadamente 11 millones de dólares, lo que representa una reducción del 60% en el total de pasivos al 31 de marzo de 2025.
La reducción de pasivos incluye el pago de 3,26 millones de dólares en honorarios diferidos para aseguradores, 1,08 millones de dólares en cuentas por pagar comerciales, la conversión de 6,56 millones de dólares de principal e intereses en acciones comunes, y el rescate de 250,000 dólares en notas convertibles. La empresa planea utilizar los nuevos fondos para capital de trabajo y propósitos corporativos generales, mientras continúa con su estrategia de añadir Bitcoin a su balance.
OneMedNet (나스닥: ONMD)는 규제 등급의 실제 데이터 기반 영상 제공업체로서, 주당 0.42달러의 사모 발행을 통해 370만 달러의 자금을 확보했습니다. 회사는 2025년 3월 31일 기준 총 부채를 약 1,100만 달러 줄여 60%의 부채 감소를 이루며 재무 상태를 크게 개선했습니다.
부채 감소에는 연기된 인수 수수료 326만 달러 지급, 무역 채무 108만 달러 상환, 원금 및 이자 656만 달러를 보통주로 전환, 그리고 전환사채 25만 달러 상환이 포함됩니다. 회사는 이번 자금을 운전자본과 일반 기업 목적에 사용할 계획이며, 동시에 비트코인을 자산에 추가하는 전략을 계속할 예정입니다.
OneMedNet (Nasdaq : ONMD), fournisseur de données d'imagerie Real-World de qualité réglementaire, a obtenu un financement de 3,7 millions de dollars par le biais de placements privés à 0,42 dollar par action. L'entreprise a également amélioré sa situation financière en réduisant ses passifs d'environ 11 millions de dollars, soit une diminution de 60 % des passifs totaux au 31 mars 2025.
La réduction des passifs inclut le règlement de 3,26 millions de dollars de frais différés d'intermédiaires, 1,08 million de dollars de dettes commerciales, la conversion de 6,56 millions de dollars de principal et intérêts en actions ordinaires, ainsi que le rachat de 250 000 dollars de billets convertibles. La société prévoit d'utiliser ce nouveau financement pour le fonds de roulement et des fins générales d'entreprise, tout en poursuivant sa stratégie d'ajouter du Bitcoin à son bilan.
OneMedNet (Nasdaq: ONMD), ein Anbieter von regulatorisch hochwertigen Real-World-Daten aus der Bildgebung, hat 3,7 Millionen US-Dollar durch Privatplatzierungen zu einem Preis von 0,42 US-Dollar pro Aktie erhalten. Das Unternehmen hat seine finanzielle Lage zudem deutlich verbessert, indem es die Verbindlichkeiten bis zum 31. März 2025 um etwa 11 Millionen US-Dollar reduziert hat, was einer Reduzierung der Gesamtverbindlichkeiten um 60 % entspricht.
Die Reduzierung der Verbindlichkeiten umfasst die Begleichung von 3,26 Millionen US-Dollar an aufgeschobenen Underwriter-Gebühren, 1,08 Millionen US-Dollar an Handelsverbindlichkeiten, die Umwandlung von 6,56 Millionen US-Dollar an Kapital und Zinsen in Stammaktien sowie die Rückzahlung von 250.000 US-Dollar an Wandelanleihen. Das Unternehmen plant, die neuen Mittel für das Betriebskapital und allgemeine Unternehmenszwecke zu verwenden und dabei seine Strategie fortzusetzen, Bitcoin in die Bilanz aufzunehmen.
- Secured $3.7 million in new funding through private placement
- Significant 60% reduction in total liabilities (approximately $11 million)
- Company founders and directors participated in the private placement, showing insider confidence
- Private placement price exceeded Nasdaq minimum requirements
- Conversion of $6.56 million debt to equity improves balance sheet structure
- Dilution of existing shareholders through new share issuance and debt conversion
- Private placement price of $0.42 per share may indicate relatively low valuation
- Continued need for additional working capital through equity raises
Insights
OneMedNet strengthened its balance sheet with $3.7M new capital and $11M liability reduction, significantly improving financial health.
OneMedNet has executed a comprehensive balance sheet restructuring that addresses both sides of the financial equation. The company secured
More impressive is the
The debt-to-equity conversion is particularly significant as it reduces interest expense, eliminates future cash obligations, and simplifies the capital structure. The company has also eliminated a convertible note with "discounted conversion features" that could have been more dilutive to shareholders had it remained outstanding.
The mention of continuing a strategy of "adding Bitcoin to the balance sheet" indicates the company is pursuing a treasury diversification approach that could serve as an inflation hedge, though it adds an element of volatility. This financial restructuring provides OneMedNet with increased operational flexibility and potentially extends its runway as it continues developing its imaging Real-World Data business.
MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading provider of regulatory-grade imaging Real-World Data (iRWD), today announced that it has entered into agreements with accredited investors in private placement transactions at
OneMedNet intends to use the proceeds of these private placements for working capital and general corporate purposes. The private placements closed on or about June 19, 2025, and the price per share of common stock sold in these private placements exceeded the minimum price requirement under Nasdaq rules.
During the second quarter of 2025, the Company took additional steps to strengthen its balance sheet and enable it to continue its strategy of adding Bitcoin to the balance sheet:
- Settling approximately
$3.26 million of deferred underwriter fees payable to the underwriter in the Company’s business combination transaction. - Settling approximately
$1.08 million additional trade payables and other amounts owed by the Company. - Obtaining notices from the Company’s noteholders to convert approximately
$6.56 million of their principal and interest into Company common stock. - Redeeming for cash the remaining
$250,000 outstanding under the Company’s original convertible promissory note previously issued to Yorkville Advisors Global in June 2024, which contained certain discounted conversion features.
As a result of these actions, the Company settled or converted approximately
This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
The offer and sale of the securities in the private placement transactions described above are being made in a transaction not involving a public offering and the securities have not been registered under the Securities Act of 1933, as amended, and may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements. The Company agreed to register the shares issued in these private placements with the SEC.
About OneMedNet Corporation
OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,400 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information.
Learn more at www.onemednet.com
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
OneMedNet Contacts:
Michael Wong, VP of Marketing
Email: michael.wong@onemednet.com
SOURCE: ONEMEDNET CORPORATION
FAQ
How much funding did OneMedNet (ONMD) raise in the June 2025 private placement?
What is the total liability reduction announced by OneMedNet (ONMD)?
How will OneMedNet (ONMD) use the proceeds from the private placement?
What debt conversions were included in OneMedNet's liability reduction?
What was the price per share for OneMedNet's private placement in June 2025?
